Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury

Journal of Pineal Research

Volumn 45, Issue 2, 2008, Pages 149-156

  Esposito, Emanuela ^a,b   Genovese, Tiziana ^b   Caminiti, Rocco ^c   Bramanti, Placido ^b   Meli, Rosaria ^a   Cuzzocrea, Salvatore ^b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Free radicals; Inflammation; Metalloproteinase; Spinal cord damage; Spinal cord injury

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MELATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; LIPID PEROXIDATION; MOUSE; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; SPINAL CORD; SPINAL CORD INJURY; ZYMOGRAPHY;

ANIMALS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; LIPID PEROXIDATION; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MELATONIN; MICE; SPINAL CORD INJURIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 49549105511     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2008.00569.x     Document Type: Article

References (77)

1. Stover SL, Fine PR. The epidemiology and economics of spinal cord injury. Paraplegia 1987 25 : 225 228.
2. Tator CH. Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol 1995 5 : 407 413.
3. Hausmann ON. Post-traumatic inflammation following spinal cord injury. Spinal Cord 2003 41 : 369 378.
4. Beattie MS. Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol Med 2004 10 : 580 583.
5. Carlson GD, Gorden C. Current developments in spinal cord injury research. Spine J 2002 2 : 116 128.
6. Anderson AJ. Mechanisms and pathways of inflammatory responses in CNS trauma: spinal cord injury. J Spinal Cord Med 2002 25 : 70 79.
7. Bethea JR, Dietrich WD. Targeting the host inflammatory response in traumatic spinal cord injury. Curr Opin Neurol 2002 15 : 355 360.
8. Noble LJ, Donovan F, Igarashi T et al. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 2002 22 : 7526 7535.
9. Castaneda FE, Walia B, Vijay-Kumar M et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology 2005 129 : 1991 2008.
10. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002 3 : 207 214.
11. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004 16 : 558 564.
12. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001 17 : 463 516.
13. Swarnakar S, Mishra A, Ganguly K et al. Matrix metalloproteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice. J Pineal Res 2007 43 : 56 64.
14. La Fleur M, Underwood JL, Rappolee DA, Werb Z. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 1996 184 : 2311 2326.
15. Shapiro SD. A concise yet informative stroll through matrix metalloproteinases and TIMPs. J Cell Sci 2000 113 : 3355 3356.
16. Vaillant C, Didier-Bazès M, Hutter A, Belin MF, Thomasset N. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J Neurosci 1999 19 : 4994 5004.
17. Shubayev VI, Myers RR. Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 2000 855 : 83 89.
18. Duchossoy Y, Arnaud S, Feldblum S. Matrix metalloproteinases: potential therapeutic target in spinal cord injury. Clin Chem Lab Med 2001 39 : 362 367.
19. Jiang X, Namura S, Nagata I. Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice. Neurosci Lett 2001 305 : 41 44.
20. Yong VW, Power C, Forsyth P et al. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001 2 : 502 511.
21. Wells JE, Rice TK, Nuttall RK et al. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci 2003 23 : 10107 10115.
22. Hsu JY, Mckeon R, Goussev S et al. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci 2006 26 : 9841 9850.
23. Fu X, Kassim SY, Parks WC et al. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 2001 276 : 41279 41287.
24. English JL, Kassiri Z, Koskivirta I et al. Individual TIMP deficiencies differentially impact pro-MMP-2 activation. J Biol Chem 2006 281 : 10337 10346.
25. Tan DX, Manchester LC, Hardeland R et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003 34 : 75 78.
26. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007 42 : 386 393.
27. Gilad E, Cuzzocrea S, Zingarelli B et al. Melatonin is a scavenger of peroxinitrite. Life Sci 1997 60 : 169 174.
28. Hardeland R, Backhaus C, Fadavi A. Reactions of the NO redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine. J Pineal Res 2007 43 : 382 388.
29. Cuzzocrea S, Zingarelli B, Gilad E et al. Protective effect of melatonin in carrageenan-induced models of local inflammation. J Pineal Res 1997 23 : 106 116.
30. León J, Escames G, Rodríguez MI, López LC et al. Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5- methoxykynuramine, a brain metabolite of melatonin. J Neurochem 2006 98 : 2023 2033.
31. Cuzzocrea S, Tan DX, Costantino G et al. The protective role of endogenous melatonin in carrageenan-induced pleurisy in the rat. FASEB J 1999 13 : 1930 1938.
32. Genovese T, Mazzon E, Crisafulli C et al. Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma. J Pineal Res 2007 43 : 140 153.
33. Genovese T, Mazzon E, Muia C et al. Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin. J Pineal Res 2005 38 : 198 208.
34. Mullane K. Neutrophil-platelet interactions and post-ischemic myocardial injury. Prog Clin Biol Res 1989 301 : 39 51.
35. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979 95 : 351 358.
36. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980 102 : 196 202.
37. Kalkan E, Cicek O, Unlu A et al. The effects of prophylactic zinc and melatonin application on experimental spinal cord ischemia-reperfusion injury in rabbits: experimental study. Spinal Cord 2007 45 : 722 730.
38. Liu JB, Tang TS, Yang HL et al. Antioxidation of melatonin against spinal cord injury in rats. Chin Med J 2004 117 : 571 575.
39. Cuzzocrea S, Genovese T, Mazzon E et al. Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma. J Pharmacol Exp Ther 2006 319 : 127 138.
40. Glaser J, Gonzalez R, Sadr E et al. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury. J Neurosci Res 2006 84 : 724 734.
41. Xiong Y, Rabchevsky AG, Hall ED. Role of peroxynitrite in secondary oxidative damage after spinal cord injury. J Neurochem 2007 100 : 639 649.
42. Tator CH. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 1991 37 : 291 302.
43. Anderson DK, Hall ED. Pathophysiology of spinal cord trauma. Ann Emerg Med 1993 22 : 987 992.
44. Bao F, Dewitt DS, Prough DS et al. Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: reduction by Mn (III) tetrakis (4-benzoic acid) porphyrin. J Neurosci Res 2003 71 : 220 227.
45. Genovese T, Mazzon E, Mariotto S et al. Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury. J Neurosurg Spine 2006 4 : 145 153.
46. Liu D, Bao F, Prough DS et al. Peroxynitrite generated at the level produced by spinal cord injury induces peroxidation of membrane phospholipids in normal rat cord: reduction by a metalloporphyrin. J Neurotrauma 2005 22 : 1123 1133.
47. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
48. Reiter RJ, Tan DX, Poeggeler B et al. Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann N Y Acad Sci 1994 719 : 1 12.
49. Leon J, Acuna-Castroviejo D, Escames G et al. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005 38 : 1 9.
50. Onuki J, Almeida EA, Medeiros MH et al. Inhibition of 5-aminolevulinic acid-induced DNA damage by melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, quercetin or resveratrol. J Pineal Res 2005 38 : 107 115.
51. Ganguly K, Maity P, Reiter RJ et al. Effect of melatonin on secreted and induced matrix metalloproteinase-9 and -2 activity during prevention of indomethacin-induced gastric ulcer. J Pineal Res 2005 39 : 307 315.
52. Bilici D, Suleyman H, Banoglu Z et al. Melatonin prevents ethanol-induced gastric mucosal damage possibly due to its antioxidant effect. Dig Dis Sci 2002 47 : 856 861.
53. Rosen J, Than NN, Koch D et al. Interactions of melatonin and its metabolites with the Abts cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res 2006 41 : 374 381.
54. Chen HY, Chen TY, Lee MY et al. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res 2006 41 : 175 182.
55. Rosenberg GA, Dencoff JE, Mcguire PG et al. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. Lab Invest 1994 71 : 417 422.
56. Rosenberg GA, Estrada EY, Dencoff JE et al. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res 1995 703 : 151 155.
57. Rosenberg GA, Dencoff JE, Correa N Jr. et al. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 1996 46 : 1626 1632.
58. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998 29 : 2189 2195.
59. Lempinen M, Inkinen K, Wolff H et al. Matrix metalloproteinases 2 and 9 in indomethacin-induced rat gastric ulcer. Eur Surg Res 2000 32 : 169 176.
60. Mori N, Sato H, Hayashibara T et al. Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB. Gastroenterology 2003 124 : 983 992.
61. Genovese T, Mazzon E, Crisafulli C et al. TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome. Shock 2008 29 : 32 41.
62. Genovese T, Mazzon E, Crisafulli C et al. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 2006 316 : 1006 1016.
63. Liu J, Marino MW, Wong G et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 1998 4 : 78 83.
64. Ousman SS, David S. MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 2001 21 : 4649 4656.
65. Pearse DD, Pereira FC, Stolyarova A et al. Inhibition of tumour necrosis factor-alpha by antisense targeting produces immunophenotypical and morphological changes in injury-activated microglia and macrophages. Eur J Neurosci 2004 20 : 3387 3396.
66. Pineau I, Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 2007 500 : 267 285.
67. Shafit-Zagardo B, Sharma N, Berman JW et al. CSF-1 expression is upregulated in astrocyte cultures by IL-1 and TNF and affects microglial proliferation and morphology in organotypic cultures. Int J Dev Neurosci 1993 11 : 189 198.
68. Sharma HS, Winkler T, Stalberg E et al. Topical application of TNF-alpha antiserum attenuates spinal cord trauma induced edema formation, microvascular permeability disturbances and cell injury in the rat. Acta Neurochir Suppl 2003 86 : 407 413.
69. Genovese T, Mazzon E, Rossi A et al. Involvement of 5-lipoxygenase in spinal cord injury. J Neuroimmunol 2005 166 : 55 64.
70. Crocker SJ, Whitmire JK, Frausto RF et al. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1- deficient mice. Am J Pathol 2006 169 : 2104 2116.
71. Holtz A, Nystrom B, Gerdin B. Spinal cord injury in rats: inability of nimodipine or anti-neutrophil serum to improve spinal cord blood flow or neurologic status. Acta Neurol Scand 1989 79 : 460 467.
72. Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 1994 6 : 712 724.
73. Taoka Y, Okajima K, Uchiba M et al. Role of neutrophils in spinal cord injury in the rat. Neuroscience 1997 79 : 1177 1182.
74. Carlson SL, Parrish ME, Springer JE et al. Acute inflammatory response in spinal cord following impact injury. Exp Neurol 1998 151 : 77 88.
75. Delclaux C, Delacourt C, D'Ortho MP et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996 14 : 288 295.
76. Buss A, Pech K, Kakulas BA et al. Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury. BMC Neurol 2007 7 : 17.
77. De Castro RC Jr., Burns CL, Mcadoo DJ et al. Metalloproteinase increases in the injured rat spinal cord. Neuroreport 2000 11 : 3551 3554.